AC
OVID icon

AXQ Capital’s Ovid Therapeutics OVID Stock Holding History

AXQ Capital’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$190K Buy
+85,411
New +$153K 0.02% 768

Other funds holding OVID

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

AXQ Capital's OVID Position: Q1 2026 in Review

AXQ Capital opened a new position in Ovid Therapeutics (OVID) in Q1 2026: 85,411 shares worth $190K. The stake represents 0.02% of the portfolio and ranks #768 among its holdings.

103 funds tracked by Wall St. Rank hold OVID as of Q1 2026.

  • AXQ Capital held 85,411 shares of Ovid Therapeutics worth $190K as of Q1 2026.
  • Ovid Therapeutics was a new AXQ Capital position in Q1 2026.
  • Ovid Therapeutics made up 0.02% of AXQ Capital's portfolio in Q1 2026, its #768 holding.
  • 103 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q1 2026.

Based on AXQ Capital's 13F filing for Q1 2026, filed 13 May 2026.